Picture of BioSino Bio-technology and Science logo

8247 BioSino Bio-technology and Science Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for BioSino Bio-technology and Science, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue295303397325348
Cost of Revenue
Gross Profit137120168111144
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses261306496314333
Operating Profit33.8-2.78-98.511.315.4
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes24.8-14.5-1152.156.41
Provision for Income Taxes
Net Income After Taxes21.2-16.7-118-0.7063.16
Minority Interest
Net Income Before Extraordinary Items
Net Income25.2-2.05-1102.72-1.14
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income25.2-2.05-1102.72-1.14
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.067-0.014-0.201-0.021-0.005
Dividends per Share

Or unlock with your email

Or unlock with your email